CALC Chief Medical Officer Sudarshan Hebbar Buys $100K of Stock
Sudarshan Hebbar, CALC's Chief Medical Officer, purchased 124,486 shares at $0.80 each.
Reviewed by automated data checks against the source filing. How we make and check alerts
Sudarshan Hebbar, Chief Medical Officer at CalciMedica, Inc. ($CALC), bought 124,486 shares at an average price of $0.80, worth about $99,588.80, on June 25, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $CALC is up 54.3% after 1 week, up 12.5% after 1 month and down 66.8% to date (from the $3.13 close on Jun 25, 2026).
CALC
CalciMedica, Inc.
Key Points
- Sudarshan Hebbar, Chief Medical Officer at CALC, bought 124,486 shares at $0.80 each, totaling $99,588.80 on June 25, 2026.
- CALC shares traded near $0.82 on Monday, with significant insider buying activity reported.
- Peer funds like Jane Street Group and Renaissance Technologies also adjusted their CALC holdings.
Get $CALC trade alerts by text
We text you when insiders, Congress or big funds trade $CALC. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated CalciMedica, Inc. alert may contain errors. Disclosures
Sudarshan Hebbar, the Chief Medical Officer at CALC, purchased 124,486 shares of the company at a price of $0.80 each, totaling $99,588.80. This transaction took place on June 25, 2026, and was not part of a pre-planned trading scheme.
Insider Buying and Selling at CalciMedica, Inc.
Besides Hebbar, several other insiders also bought shares of CALC on June 25, 2026. Rachel Leheny, the CEO, acquired 186,729 shares, while Robert Wilson purchased 1,182,621 shares. Fred Middleton and Eric Roberts, the Chief Business Officer, bought 248,972 and 186,729 shares respectively. All these transactions were conducted at the same price of $0.80 per share.
Other Institutional Activity in CALC
Several institutional investors have also been active with CALC shares. Jane Street Group increased its holdings by 159,312 shares, bringing its total to 178,515 shares valued at approximately $96,398, marking an 829.6% increase. Vanguard Capital Management opened a new position with 169,110 shares valued at $91,319. Renaissance Technologies added 39,775 shares, ending with 128,075 shares worth about $69,161, which is a 45.0% increase. 180 Wealth Advisors expanded its position by 94,650 shares, now holding 126,500 shares valued at $68,310, reflecting a 297.2% rise. Geode Capital Management increased its stake by 23,595 shares to a total of 123,382 shares, valued at $66,652, representing a 23.6% increase.
Analysts Set New Price Targets
Analysts have shown interest in CALC, with Oppenheimer maintaining a 'buy' rating and setting a price target of $10.00 on March 5, 2026. Previously, HC Wainwright & Co. reiterated a 'buy' rating with a $16.00 target on March 4, 2025. These ratings suggest continued confidence in CALC's potential.
Bottom Line
Sudarshan Hebbar's significant share purchase in CALC highlights insider confidence in the company's prospects. With both insiders and institutional investors actively buying, market participants are closely watching CALC. It's important to remember that these transactions are part of the company's historical data and may not reflect current positions.
Related Filing Alerts
Source: Sudarshan Hebbar's Form 4 filing on $CALC (Jun 25, 2026). Find the original filing: CALC Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts